Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities

Cash Flow Statement

Daily Values

Growth Metrics

Arcadia Biosciences (RKDA) Goodwill (2020 - 2021)

Arcadia Biosciences' Goodwill history spans 2 years, with the latest figure at $1.2 million for Q4 2021.

For Q4 2021, Goodwill rose 203.92% year-over-year to $1.2 million; the TTM value through Dec 2021 reached $1.2 million, up 203.92%, while the annual FY2021 figure was $1.2 million, 203.92% up from the prior year.
Goodwill reached $1.2 million in Q4 2021 per RKDA's latest filing, down from $1.6 million in the prior quarter.
In the past five years, Goodwill ranged from a high of $1.6 million in Q2 2021 to a low of $301000.0 in Q3 2020.